Analgesic Effects of Ultrasound-guided Dry-Needling Therapy for Neck and Head Pain

Neck Pain Clinical Trial

Official title:

Analgesic Effects of Ultrasound-guided Dry-Needling Therapy for Neck and Head Pain by Active and Latent Myofascial Trigger Points.

Clinical Trial Details — Status: Suspended

Administrative data

• NCT number: NCT03869710
• Other study ID #: 0209913/17
• Status: Suspended
• Phase: N/A
• Start date: March 8, 2019
• Est. completion date: December 25, 2023

Study information

• Verified date: June 2023
• Source: San Salvatore Hospital of L'Aquila
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The analgesic effects of ultrasound-guided dry-needling therapy will be evaluated in the management of head and neck pain.

Description:

The analgesic effects of ultrasound-guided dry-needling therapy will be evaluated in the management of head and neck pain by myofascial active and latent trigger point.

The myofascial pain control will be assessed for the superficial and deep posterolateral muscle complex of neck. The analgesic request, Range Of Motion (ROM), Motion Related Pain (MRP) and the quality of life, will be also assessed.

Recruitment information / eligibility

• Status: Suspended
• Enrollment: 43
• Est. completion date: December 25, 2023
• Est. primary completion date: December 25, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Chronic neck pain

• Chronic head pain

Exclusion Criteria:

• previous surgery of neck and head

• Body Mass Index > 39,99

• politrauma patients

• pregnancy

• neck and head infections

Related Conditions & MeSH terms

• Head Pain
• Headache
• Neck Pain

Intervention

Device:
• Ultrasound-guided Dry-Needling Therapy
The needle will be insert under ultrasound guidance to elicit the myofascial response on the neck of the patients

Locations

Country	Name	City	State
Italy	San Salvatore Academic Hospital	Coppito	L'Aquila

Sponsors (1)

Lead Sponsor	Collaborator
San Salvatore Hospital of L'Aquila

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Trigger Point	The number of the elicited myofascial trigger points assessed during dry-needling treatment	The first hour of the treatment
Secondary	Analgesic request	The analgesic request will be assessed in mg of equianalgesic morphine	3 months trom treatment
Secondary	Karnofsky Performance Status	The quality of life assessed by Karnofsky Performance Status (a 0-100 steps scale, from 0 [Dead] to 100 [Normal no complaints; no evidence of disease]).	3 months from treatment
Secondary	Range Of Motion (ROM)	The alpha angle expressed in degrees and assessed during	3 months after treatment
Secondary	Motion Related Pain	Pain assessed by Numeric Rating Scale (a 10-steps scale, from 0 [no pain] to 10 [worse pain]), during flexion, extension and rotation of neck and head	3 months after treatment
Secondary	Perception	Pain assessed by Numeric Rating Scale (a 10-steps scale, from 0 [no pain] to 10 [worse pain])	3 months after treatment